'Vascular depression' hypothesis

Archives of General Psychiatry

Volumn 54, Issue 10, 1997, Pages 915-922

  Alexopoulos, George S ^a   Meyers, Barnett S ^a   Young, Robert C ^a   Campbell, Scott ^a   Silbersweig, David ^a   Charlson, Mary ^a  

^a The Cornell Institute of Geriatric Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACETYLSALICYLIC ACID; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; GANGLIOSIDE; GROWTH FACTOR; METHYLPHENIDATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORTRIPTYLINE; PSYCHOTROPIC AGENT; SODIUM CHANNEL BLOCKING AGENT; TICLOPIDINE; TRAZODONE;

BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GERIATRIC DISORDER; HUMAN; REVIEW;

EID: 0031451874     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830220033006     Document Type: Review

References (131)

1. Alexopoulos GS, Clinical and biological findings in late-onset depression. In: Tasman A, Gold-finger SM, Kaufman CA, eds. Review of Psychiatry. Washington, DC: American Psychiatric Press; 1990;9:249-262.
2. Alexopoulos GS, Meyers BS, Young RC, Chartson M, Silversweig D. The clinical presentation of 'vascular depression.' In: New research program and abstracts, annual meeting of the American Psychiatric Association; May 4-9,1996; New York, NY.
3. Alexopouios GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry. 1993;34:141-145.
4. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with 'reversible dementia.' Am J Psychiafry. 1993;150:1693-1699.
5. Alexopoulos GS, Young RC, Shindledecker R. Brain computed tomography in geriatric depression and primary degenerative dementia. Biol Psychiatry. 1992;31:591-599.
6. Jacoby RJ, Levy R. Computed tomography in the elderly, 3: affective disorder. Br J Psychiatry. 1980;136:270-275.
7. Coffee CE, Figiel GS, Djang WT, Cress M, Saunders WB, Weiner RD. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiafry.1988;24:143-161.
8. Alexopoulos GS, Vrontou C, Kakuma T, Meyers BS, Young RC, Klausner E, Clarkin J. Disability in geriatric depression. Am J Psychiatry. 1996;153:877-885.
9. Roth M, Kay DWK, Affective disorders arising in the senium, II: physical disability as an etiological factor. J Ment Sci. 1956;102:141-150.
10. Jacoby RJ, Levy R, Bird JM. Computed tomography and the outcome of affective disorder: a follow-up study of elderly subjects. Br J Psychiatry. 1981;139:288-292.
11. Baron M, Mendlewicz J, Klotz J. Age of onset and genetic transmission in affective disorders. Acta Psychiatr Scand. 1981;64:373-380.
12. Conwell Y, Nelson JC, Kim KM, Majure CM. Depression in late life: age of onset as marker of a subtype. J Affect Dis. 1989;17:189-195.
13. Greenwald BS, Kramer-Ginsberg E. Age of onset in geriatric depression: relationship to clinical variables. J Affect Dis. 1988;15:61-68.
14. Herrmann N, Lieff S, Silberfeld M. The effect of age of onset on depression in the elderly. J Geriatr Psychiatry Neurol 1989;2:182-187.
15. Wiener P, Alexopoulos GS, Kakuma T, Meyers BS, Rosendhal E, Chester J. The limits of history taking in geriatric depression. Am J Geriatr Psychiatry. 1997;5:116-125.
16. Post F. The Significance of Affective Disorders in Old Age. London, England: Institute of Psychiatry; 1962. Maudsley Monograph 10.
17. Post F, Schulman K. New views on old age affective disorder. In: Aire T, ed. Recent Advances in Psychogeriatrics. New York, NY: Churchill Livingstone Inc; 1985:119-140.
18. Luber MP, Alexopoulos GS, Hollenberg J, Charlson ME, Callahan M. Recognition, treatment, co- morbidity and resource utilization of depressed patients in a general medical practice. In: Program and abstracts of the annual meeting of the Society of General Internal Medicine; May 2-4, 1996; Washington, DC.
19. Peterson JC, Williams-Russo PG, Chartson ME, Meyers BS. Longitudinal course of new onset depression after cardiac bypass surgery. In: Programs and abstracts of the 10th Annual International Conference on Mental Health Problems in the General Health Care Sector, National Institute of Mental Health; July 15-16, 1996; Bethesda, Md.
20. Rabkin JG, Charles E, Kass F. Hypertension and DSM-III depression in psychiatric outpatients. Am J Psychiatry. 1983;140:1072-1074.
21. Carney RM, Rich WM, Tevelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273-1275.
22. Sulzer DL, Levin HS, Mahler ME, High WM, Cummings JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry. 1993;150:1806-1812.
23. Starkstein SE, Robinson RG. Depression in cerebrovascular disease. In: Depression in Neurological Disease. Baltimore, Md: The Johns Hopkins University Press; 1993:28-49.
24. Folstein MF, Maiberger R, McHugh PR. Mood disorders as a specific complication of stroke. J Neurol Neurosurg Psychiatry. 1971;40:1018-1020.
25. Ebrahim S, Barer K, Nouri F. Affective illness after stroke. Br J Psychiatry. 1987;154:170-182.
26. Mendez MF, Adams NL, Lewandoski KS. Neurobehavioral changes associated with caudate lesions. Neurology. 1989;39:349-354.
27. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 1993;24:1631-1634.
28. Ryan RN, Manolio TA, Schertz LD, Jungteis C, Poirier VC, Elster AO, Kronmal RA. A method of using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. Am J Neuroradiol. 1994;15:1625-1633.
29. Krishnan KRR, Goli V, Ellinwood EH, France RD, Blazer DZ, Nemeroff CB. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry. 1988;23:519-522.
30. Coffey CE, Figiel GS, Djang WT, Cross M, Saunders WB, Weiner RD. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry. 1988;23:519-522.
31. Coffey CE, Figiel GS, Djang WT, Saunders WB, Weiner RD. White matter hyperintensity on MRI clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci. 1989;1:135-144.
32. Coffey CE, Figiel FS, Djang WT, Weiner RD. Subcortical hyperintensity on MRI: a comparison of normal and depressed elderly subjects. Am J PsyChiatry. 1990;147:187-189.
33. Coffey CE, Wilkinson WE, Weiner RD, Paraschos IA, Djang WT, Webb MC, Figiel GS, Spritzer CE. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1993;50:7-16.
34. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepler WW. Brain MRI: pathologic correlation with gross and histopathology, 2: hyperintense white-matter foci in the elderly. AJNR Am J Neuroradiol. 1988; 151:559-566.
35. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Honner S, Bertha G, Lechner H. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow, measurements, and cerebrovascular risk factors. Stroke. 1988;19:1285-1288.
36. Miller DS, Kumar A, Yousem DM, Gottlieb GL. MRI high-intensity signals in late-life depression and Alzheimer's disease: a comparison of subjects without major vascular risk factors. Am J Geriatr Psychiatry. 1994;2:332-337.
37. Lesser IM, Hill-Gutierrez E, Miller BL, Boone KB. Late-onset depression with white matter lesions. Psychosomatics. 1993;34:364-367.
38. Fujikawa T, Yamawaki S, Touhouda Y. Background factors and clinical symptoms of major depression with silent cerebral infarction. Stroke. 1994;25:798-801.
39. Baldwin RC, Tomenson B. Depression in later life: a comparison of symptoms and risk factors in early and late onset cases. Br J Psychiatry. 1995;167:649-652.
40. Krishnan KRR, Hays JC, Tupler LA, George LK, Blazer DG. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry. 1995;152:785-788.
41. Young RC, Klerman GL. Mania in late life: focus on age at onset. Am J Psychiatry. 1992;4:73-78.
42. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Sibersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry. 1997;154:562-565.
43. Kokmen E, Whisnant JP, O'Fallon WM, Chu C-P, Beard CM. Dementia after ischemic stroke: a population study in Rochester, Minnesota (1960-1984). Neurology. 1996;19:154-159.
44. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer's disease. JAMA. 1997;277:813-817.
45. Ferruzzi L, Guralnik JM, Salive ME, Pahor M, Corti MC, Baroni A, Havlik RJ. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc. 1996;44:237-241.
46. 2 signal intensity in MR images of healthy elderly subjects: a follow-up study. J Am Geriatr Soc. 1990;38:1131-1138.
47. Harell LE, Duvall E, Folks DG, Duke L, Bartolucci A, Conboy T, Callaway R, Kerns D. The relationships of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. Arch Neural. 1991;48:1136-1140.
48. Van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991;30:825-830.
49. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol. 1993;50:818-824.
50. Fein G, van Dyke C, Davenport L, Turetsky B, Brarrt-Zawadzki M, Zatz L, Dillon W. Preservation of normal cognitive functioning in elderly subjects with extensive white matter lesions of long duration. Arch Gen Psychiatry. 1990;47:220-223.
51. Tupler LA, Coffey CE, Logue PE, Djang WT, Fagan M. Neuropsychological importance of subcortical white matter hyperintensity. Arch Neurol. 1992;49:1248-1252.
52. Meyers JS, Kawamura J, Terayama Y. White matter lesions in the elderly. J Neurol Sci. 1992;110:1-7.
53. Lesser IM, Hill-Gutierrez E, Miller RL, Boone KB. Late-onset depression with white matter lesions. Psychosomatics. 1993;34:364-367.
54. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Feder M, Einhorn A, Rosendahl E. Recovery in geriatric depression. Arch Gen Psychiatry. 1996;53:305-312.
55. Leuchter AF, Dunkin JJ, Lufkin RB, Anzai Y, Cook IA, Newton TF. Effect of white matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry. 1994;57:1347-1354.
56. Leuchter A, Simon SL, Daly KA, Abrams M, Rosenberg-Thompson S, Dunkin JJ, Cook IA, Newton TF, Spar JE. Quantitative EEC correlates of outcome in older psychiatric patients, II: two-year follow-up of patients with depression. Am J Geriatr Psychiatry. 1994;2:290-299.
57. Alexopoulos GS. The subtypes of geriatric depression. In: Programs and abstracts of the annual meeting of the American Geriatric Association; March 5,1997; Orlando, Fla.
58. Boone KB, Miller BL, Lesser IM, Merhinger CM, Hill-Gutierrez E, Goldberg M, Berman NG. Neuropsychological correlates of white matter lesions in healthy elderly subjects. Arch Neurol. 1992;49:549-554.
59. Damasio AR, Van Hoesen GW. Emotional disturbances associated with focal lesions of the limbic frontal lobe. In: Heilman KM, Satz P, eds. Neuropsychology of Human Emotion. New York, NY: Guilford Press; 1983:85-110.
60. Grafman J, Vance SC, Weingartner H, Salazar AM, Amin D. The effects of lateralized frontal lesions on mood regulation. Brain. 1986;109:1127-1148.
61. Eslinger PJ, Damasio AR. Severe bilateral disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology. 1985;35:1731-1741.
62. Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint. In: Weiner WJ, Lang AE, eds. Behavioral Neurology of Movement Disorders: Advances in Neurology. New York, NY: Raven Press; 1995;65:49-60.
63. Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol. 1988;45:725-730.
64. Krishnan KRR. Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatry Neurol. 1993;6:39-58.
65. Krishnan KRR, McDonald WM. Arteriosclerotic depression. Med Hypotheses. 1995;44:111-115.
66. Krishnan KRR, McDonald WM, Escalona PR, Doraiswamy PM, Na C, Husain MM, Figiel GS, Boyko OB, Ellinwood EH, Nemeroff CB. Magnetic resonance imaging of the caudate nuclei in depression. Arch Gen Psychiatry. 1992;49:553-557.
67. Husain MM, McDonald WM, Doraiswamy PM, Figiel GS, Escalona PR, Boyko OB, Nemeroff CB, Krishnan KRR. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res Neuroimaging. 1991;40:95-99.
68. Alexopoulos GS, Meyers BS, Bajulaiye R, Elkin C, Khouri P, Kakuma T. Caudate size in geriatric depression. In: New research program and abstracts, annual meeting of the American Psychiatric Association; May 20-25,1995; Miami, Fla,
69. Baxter LR Jr, Phelps ME, Mazziotta JC, Schwarte JM, Gerner RH, Selin CE, Smida RM, Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose. Arch Gen Psychiatry, 1985;42:441-447.
70. Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, Pappata S, Syrota A. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry. 1990;147:1313-1317.
71. Bench CJ, Fristen KJ, Brown RG, Scott LC, Frackowiak RSJ, Dolan RJ. The anatomy of melancholia: focal abnormalities of cerebral blood flow in major depression. Psychol Med, 1992;22:607-615.
72. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RSJ. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psyc/wafry.1992;55:768-773.
73. Drevets WC, Videen TO, Preskorn SH, Price JL, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J Neurosci. 1992;12:3628-3641.
74. Ketter TA. Andreason PJ, George MS, Pazzaglia PJ, Marangell LM, Post RM. Blunted CBF response to procaine in mood disorders. In: New research program and abstracts, annual meeting of the American Psychiatric Association: May 22-27,1993; San Francisco, Calif. Abstract NR297.
75. George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression. 1994;2:59-72.
76. Baxter LR Jr, Schwartz JM, Phelps ME, Mazzi- otta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 1989;46:243-250.
77. Finkelstein SP, Benowitz LI, Baldessarini RJ, Arana GW, Levine D, Woo E, Bear D, Moya K, Stoll AL Mood, vegetative disturbance, and dexamethasone suppression after stroke. Ann Neurol. 1982;12:463-468.
78. Starkstein SE, Robinson RG, Honig MA, Parikh RM, Joselyn J, Price TR. Mood changes after right hemisphere lesions. Br J Psychiatry. 1989;155:79-85.
79. Robinson RG, Starr LB, Lipsey JR, Rao K, Price TR. A two-year longitudinal study of poststroke mood disorders: dynamic changes in associated variables over the first six months of followup. Stroke. 1984;15:510-516.
80. House A, Dennis M, Warlow C, Hawton K, Molyneux A. Mood disorders after stroke and their relation to lesion location: a CT scan study. Brain. 1990;113:1113-1130.
81. Finkelstein S, Campbell A, Saldessarini R, Moya KL, Haber SN. Late changes in cerebral metabolism following focal ventrolateral cerebrocortical lesions in rats. Brain Res. 1985;344:205-210.
82. Bryer JB, Starkstein SE, Votypka V, Parikh RM, Price TR, Robinson RG. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. J Neuropsychiatry Clin Neurosci. 1992;4:440-442.
83. Mayberg HS, Robinson RG, Wong DF, Parikh R, Bolduc P, Starkstein SE, Price T, Dannals RF, Links JM, Wilson AA, et al. PET imaging of cortical S2 serotonin receptors following stroke: lateralized changes and relationship to depression. Am J Psychiatry. 1988;145:937-943.
84. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986;43:954-959.
85. Ishii H, Stanmirovic DB, Chang CJ, Mrsulja BB, Spatz M. Dopamine metabolism and free-radical related mitochondrial injury during transient brain ischemia. Neurochem Res. 1993;18:1193-1201.
86. Bertrand N, Ishii H, Beley A, Spatz M. Biphasic striatal acetylcholine release during and after transient cerebral ischemia in gerbils. J Cereb Blood Flow Metab. 1993;13:789-795.
87. Kuroda H, Baskin DS, Matsui T, Loh HH, Hosobuchi Y, Lee NM. Effects of dynorphin 1-13 on opiate binding and dopamine and GABA uptake in stroked cat brain. Brain Res. 1986;376:68-74.
88. Lyden P, Lonzo L, Nunez S. Combination chemotherapy extends the therapeutic window to 60 minutes after stroke. J Nevrotrauma. 1995;12:223-230.
89. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregation circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:357-381.
90. Baxter LR Jr, Schwartz LM, Guze BH, Bergman K, Szuba MP. PET imaging in obsessive-compulsive disorder with and without depression. J Clin Psychiatry. 1990;51(suppl):61-69.
91. Baxter LR Jr. Brain imaging as a tool in establishing a theory of brain pathology in obsessive-compulsive disorder. J Clin Psychiatry. 1990;51(Suppl):22-25.
92. Kalayam B, Alexopoulos GS, Musiek FE, Kakuma T, Toro A, Silbergsweig D, Young RC. Brainstem evoked response abnormalities in late-life depression with vascular disease. AmJ Psychiatry. 1997;154:970-975.
93. Ketter TA, Andreason PJ, George MS, Marangell LM, Pazzaglia PJ, Post RM. Reduced resting frontal lobe cerebral blood flow in mood disorders. In: New research program and abstracts, annual meeting of the American Psychiatric Association; May 22-27, 1993; San Francisco, Calif. Abstract NR298.
94. George MS, Ketter TA, Gill D, Haxby JV, Ungerleider L, Herscovitch P, Post RM. Brain regions involved in recognizing facial emotion or identity: an 015 PET study. J Neuropsychiatry Clin Neurosci. 1993;54:1-10.
95. George MS, Ketter TA, Gill DS, Marangell LB, Pazzaglia PJ, Post RM. Blunted cerebral blood flow with emotion recognition in depression. In: New research program and abstracts, annual meeting of the American Psychiatric Association; May 22-27, 1993; San Francisco, Calif. Abstract NR114.
96. Berman KF, Doran AR, Pickar D, Weinberger DR. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia: regional cerebral blood flow during cognitive activation. Br J Psychiatry. 1993;162:183-192.
97. Pardo JV, Pardo PJ, Ratchle ME. Neural correlates of self-induced dysphoria. Am J Psychiatry. 1993;150:13-19.
98. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovttch P, Post RM. Regional brain activity during transient sadness or happiness in healthy women. Am J Psychiatry, 1995;152:341-351.
99. Åstrorn M, Adolfson R, Asplund K. Major depression in stroke patients: a three-year longitudinal study. Stroke. 1993;24:976-982.
100. Zubenko GS, Sullivan P, Nelson JP. Brain imaging abnormalities in mental disorders of late life. Arch Neurol. 1990;47:1107-1113.
101. Figiel GS, Krishnan KRR, Doraiswamy PM, Rao VP, Nemeroff CB, Boyko OB. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging. 1991;12:245-247.
102. Churchill CM, Priolo CV, Nemeroff CB, Krishnan KRR, Breitner JCS. Occult subcortical magnetic resonance imaging in elderly depressives. Int J Geriatr Psychiatry. 1991;6:213-214.
103. Krishnan KRR, McDonald WM, Doraiswamy PM, Tupler LA, Husain M, Boyko OB, Figiel GS, Ellinswood EH. Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci. 1993;243:41-46.
104. Kannel WB, Wolf PA, Verier J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke: the Framingham Study. JAMA. 1996;276:1269-1278.
105. Lindenstrom E, Boysen G, Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am J Epidemiol. 1995;142:1279-1290.
106. Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience). Am J Cardiol. 1996;77:6B-11 B.
107. Whisnant JP. Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Neurology. 1996;46:301-307.
108. Sirtori CR. The treatment of hypercholesterolemia in primary and secondary prevention. Ann Ital Med Int. 1995;10(suppl):48S-52S.
109. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation Study II. Lancet. 1994;343:687-691.
110. Bellavance A. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events: the ticlopidine aspirin stroke Study. Stroke. 1993;24:1452-1457.
111. Sivenius J, Riekkinen PJ, Laasko M, Smets P, Lowenthal A. European Stroke Prevention Study: antithrombotic therapy is also effective in the elderly. Acta Neurol Scand. 1993;87:111-114.
112. + response is increased in the blood platelets of depressed patients. Biol Psychiatry. 1991;30:310-312.
113. Mikuni K, Kagaya A, Takahashi K, Meltzer HY. Serotonin but not norepmephrine-mduced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology. 1992;106:311-314.
114. Silver B, Weber J, Fisher M. Medical therapy for ischemic stroke. Clin Neuropharmacol. 1996;19:101-128.
115. Hacke W, Kaste M, Fiechi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
116. Gelmers HJ, Hennerici M. Effect of nimodipine in acute ischemic stroke: pooled results from five randomized trials. Stroke. 1990;21(suppl 22):81-84.
117. Lenzi GL, Grigoletto F, Gent M, Roberts RS, Walker MD, Easton JD, Carolei A, Dorsey FC, Rocca WA, Bruno R, et al. Early treatment with monosialoganglioside GM-1: efficacy and safety results of the Early Stroke Trial. Stroke. 1994;25:1552-1558.
118. Svennerholm L. Gangliosides: a new therapeutic agent against stroke and Alzheimer's disease. Life Sci. 1994;55:2125-2134.
119. Goldstein LB. Pharmacologic modulation of recovery after stroke: clinical data. J Neurol Rehab. 1991;5:129-140.
120. Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast 1993;3:175-192.
121. The Sygen in Acute Stroke Study Investigators, Goldstein LB. Common drugs may influence motor recovery after stroke. Neurology. 1995;45:865-871.
122. Finkeistein SP, Weintraub RJ, Karmouz N, Askinazi C, Davar G, Baidessarini RJ. Antidepressant drug treatment for poststroke depression: retrospective study. Arch Phys Med Rehabil. 1987;68:772-776.
123. Reding MJ, Orto LA, Winter SW, Fortuna IM, Di Ponte P, McDowell FH. Antidepressant therapy after stroke: a double-blind trial. Arch Neurol. 1986;43:763-765.
124. Lipsey JR, Spencer WC, Rabins PV, Robinson RG. Phenomenological comparison of post-stroke depression and functional depression. Am J Psychiatry. 1986;143:527-529.
125. Lazarus LW, Moberg PJ, Langsley PR, Lingam V. Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison. Arch Med Rehab. 1994;75:403-406.
126. Masand P, Murray GB, Pickett P. Psychostimulants in poststroke depression. J Neurol Psychiatry Clin Neurosci. 1991;3:23-27.
127. Lingham VR, Lazarus LW, Groves L, Oh SH. Methylphenidate in treating poststroke depression. J Clin Psychiatry. 1988;49:151-153.
128. Lazarus LW, Winemiller DR, Lingam VR, Robinson RG. Efficacy and side effects of methylphenldate for poststroke depression. J Clin Psychiatry. 1992;53:447-449.
129. Boyerson MG, Harmon RL. Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am J Phys Med Rehab. 1993;72:286-293.
130. Boyerson MG, Harmon RL, Jones JL. Differential effects of fluoxetine, amitriptyline and serotonin S2 antagonist markedly reduces infarct size following middle cerebral artery occlusion in the rat. Neurology. 1988;38:1667-1673.
131. Dam M, Tonon P, De Boni A, Pizzolato G, Casson S, Ermani M, Freo U, Piron L, Battistin L. Effects of fluoxetine and maprotilene on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211-1214.